世界のイミペネムAPI市場予測（～2028年）：無菌API、非滅菌API

• 英文タイトル：Global Imipenem API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8851 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

イミペネムAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のイミペネムAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 イミペネムAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・無菌API、非滅菌API 用途別セグメントは次のように区分されます。 ・筋肉内注射、静的ドロップ 世界のイミペネムAPI市場の主要な市場プレーヤーは以下のとおりです。 ・Hospira、ACS DOBFAR SPA、High Science、Jeil Pharmaceutica、Choongwae Pharma Corporation、Sun Pharmaceutical、Sandoz、Kaliberr、Auronext Pharma、Nectar Lifesciences、Savior Lifetec Corporation、Zhuhai United Laboratorie、SUZHOU HOMESUN PHARMACEUTICAL、Unimark Remedies、Zhejiang Haixiang Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、イミペネムAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なイミペネムAPIメーカーの企業概要、2019年～2022年までのイミペネムAPIの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なイミペネムAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別イミペネムAPIの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのイミペネムAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのイミペネムAPI市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびイミペネムAPIの産業チェーンを掲載しています。 ・第13、14、15章では、イミペネムAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Hospira、ACS DOBFAR SPA、High Science、Jeil Pharmaceutica、Choongwae Pharma Corporation、Sun Pharmaceutical、Sandoz、Kaliberr、Auronext Pharma、Nectar Lifesciences、Savior Lifetec Corporation、Zhuhai United Laboratorie、SUZHOU HOMESUN PHARMACEUTICAL、Unimark Remedies、Zhejiang Haixiang Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：無菌API、非滅菌API ・用途別分析2017年-2028年：筋肉内注射、静的ドロップ ・イミペネムAPIの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・イミペネムAPIのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・イミペネムAPIのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・イミペネムAPIの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・イミペネムAPIの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Imipenem API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Imipenem API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Intramuscular Injection accounting for % of the Imipenem API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Aseptic API segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Imipenem API include Hospira, ACS DOBFAR SPA, High Science, Jeil Pharmaceutica, and Choongwae Pharma Corporation, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Imipenem API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Aseptic API
Non-sterile API
Market segment by Application can be divided into
Intramuscular Injection
Static Drops
The key market players for global Imipenem API market are listed below:
Hospira
ACS DOBFAR SPA
High Science
Jeil Pharmaceutica
Choongwae Pharma Corporation
Sun Pharmaceutical
Sandoz
Kaliberr
Auronext Pharma
Nectar Lifesciences
Savior Lifetec Corporation
Zhuhai United Laboratorie
SUZHOU HOMESUN PHARMACEUTICAL
Unimark Remedies
Zhejiang Haixiang Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Imipenem API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Imipenem API, with price, sales, revenue and global market share of Imipenem API from 2019 to 2022.
Chapter 3, the Imipenem API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Imipenem API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Imipenem API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Imipenem API.
Chapter 13, 14, and 15, to describe Imipenem API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Imipenem API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Imipenem API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Aseptic API
1.2.3 Non-sterile API
1.3 Market Analysis by Application
1.3.1 Overview: Global Imipenem API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Intramuscular Injection
1.3.3 Static Drops
1.4 Global Imipenem API Market Size & Forecast
1.4.1 Global Imipenem API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Imipenem API Sales in Volume (2017-2028)
1.4.3 Global Imipenem API Price (2017-2028)
1.5 Global Imipenem API Production Capacity Analysis
1.5.1 Global Imipenem API Total Production Capacity (2017-2028)
1.5.2 Global Imipenem API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Imipenem API Market Drivers
1.6.2 Imipenem API Market Restraints
1.6.3 Imipenem API Trends Analysis
2 Manufacturers Profiles
2.1 Hospira
2.1.1 Hospira Details
2.1.2 Hospira Major Business
2.1.3 Hospira Imipenem API Product and Services
2.1.4 Hospira Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 ACS DOBFAR SPA
2.2.1 ACS DOBFAR SPA Details
2.2.2 ACS DOBFAR SPA Major Business
2.2.3 ACS DOBFAR SPA Imipenem API Product and Services
2.2.4 ACS DOBFAR SPA Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 High Science
2.3.1 High Science Details
2.3.2 High Science Major Business
2.3.3 High Science Imipenem API Product and Services
2.3.4 High Science Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Jeil Pharmaceutica
2.4.1 Jeil Pharmaceutica Details
2.4.2 Jeil Pharmaceutica Major Business
2.4.3 Jeil Pharmaceutica Imipenem API Product and Services
2.4.4 Jeil Pharmaceutica Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Choongwae Pharma Corporation
2.5.1 Choongwae Pharma Corporation Details
2.5.2 Choongwae Pharma Corporation Major Business
2.5.3 Choongwae Pharma Corporation Imipenem API Product and Services
2.5.4 Choongwae Pharma Corporation Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Sun Pharmaceutical
2.6.1 Sun Pharmaceutical Details
2.6.2 Sun Pharmaceutical Major Business
2.6.3 Sun Pharmaceutical Imipenem API Product and Services
2.6.4 Sun Pharmaceutical Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Sandoz
2.7.1 Sandoz Details
2.7.2 Sandoz Major Business
2.7.3 Sandoz Imipenem API Product and Services
2.7.4 Sandoz Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Kaliberr
2.8.1 Kaliberr Details
2.8.2 Kaliberr Major Business
2.8.3 Kaliberr Imipenem API Product and Services
2.8.4 Kaliberr Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Auronext Pharma
2.9.1 Auronext Pharma Details
2.9.2 Auronext Pharma Major Business
2.9.3 Auronext Pharma Imipenem API Product and Services
2.9.4 Auronext Pharma Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Nectar Lifesciences
2.10.1 Nectar Lifesciences Details
2.10.2 Nectar Lifesciences Major Business
2.10.3 Nectar Lifesciences Imipenem API Product and Services
2.10.4 Nectar Lifesciences Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Savior Lifetec Corporation
2.11.1 Savior Lifetec Corporation Details
2.11.2 Savior Lifetec Corporation Major Business
2.11.3 Savior Lifetec Corporation Imipenem API Product and Services
2.11.4 Savior Lifetec Corporation Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zhuhai United Laboratorie
2.12.1 Zhuhai United Laboratorie Details
2.12.2 Zhuhai United Laboratorie Major Business
2.12.3 Zhuhai United Laboratorie Imipenem API Product and Services
2.12.4 Zhuhai United Laboratorie Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 SUZHOU HOMESUN PHARMACEUTICAL
2.13.1 SUZHOU HOMESUN PHARMACEUTICAL Details
2.13.2 SUZHOU HOMESUN PHARMACEUTICAL Major Business
2.13.3 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Product and Services
2.13.4 SUZHOU HOMESUN PHARMACEUTICAL Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Unimark Remedies
2.14.1 Unimark Remedies Details
2.14.2 Unimark Remedies Major Business
2.14.3 Unimark Remedies Imipenem API Product and Services
2.14.4 Unimark Remedies Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Zhejiang Haixiang Pharmaceutical
2.15.1 Zhejiang Haixiang Pharmaceutical Details
2.15.2 Zhejiang Haixiang Pharmaceutical Major Business
2.15.3 Zhejiang Haixiang Pharmaceutical Imipenem API Product and Services
2.15.4 Zhejiang Haixiang Pharmaceutical Imipenem API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Imipenem API Breakdown Data by Manufacturer
3.1 Global Imipenem API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Imipenem API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Imipenem API
3.4 Market Concentration Rate
3.4.1 Top 3 Imipenem API Manufacturer Market Share in 2021
3.4.2 Top 6 Imipenem API Manufacturer Market Share in 2021
3.5 Global Imipenem API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Imipenem API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Imipenem API Market Size by Region
4.1.1 Global Imipenem API Sales in Volume by Region (2017-2028)
4.1.2 Global Imipenem API Revenue by Region (2017-2028)
4.2 North America Imipenem API Revenue (2017-2028)
4.3 Europe Imipenem API Revenue (2017-2028)
4.4 Asia-Pacific Imipenem API Revenue (2017-2028)
4.5 South America Imipenem API Revenue (2017-2028)
4.6 Middle East and Africa Imipenem API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Imipenem API Sales in Volume by Type (2017-2028)
5.2 Global Imipenem API Revenue by Type (2017-2028)
5.3 Global Imipenem API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Imipenem API Sales in Volume by Application (2017-2028)
6.2 Global Imipenem API Revenue by Application (2017-2028)
6.3 Global Imipenem API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Imipenem API Sales by Type (2017-2028)
7.2 North America Imipenem API Sales by Application (2017-2028)
7.3 North America Imipenem API Market Size by Country
7.3.1 North America Imipenem API Sales in Volume by Country (2017-2028)
7.3.2 North America Imipenem API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Imipenem API Sales by Type (2017-2028)
8.2 Europe Imipenem API Sales by Application (2017-2028)
8.3 Europe Imipenem API Market Size by Country
8.3.1 Europe Imipenem API Sales in Volume by Country (2017-2028)
8.3.2 Europe Imipenem API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Imipenem API Sales by Type (2017-2028)
9.2 Asia-Pacific Imipenem API Sales by Application (2017-2028)
9.3 Asia-Pacific Imipenem API Market Size by Region
9.3.1 Asia-Pacific Imipenem API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Imipenem API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Imipenem API Sales by Type (2017-2028)
10.2 South America Imipenem API Sales by Application (2017-2028)
10.3 South America Imipenem API Market Size by Country
10.3.1 South America Imipenem API Sales in Volume by Country (2017-2028)
10.3.2 South America Imipenem API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Imipenem API Sales by Type (2017-2028)
11.2 Middle East & Africa Imipenem API Sales by Application (2017-2028)
11.3 Middle East & Africa Imipenem API Market Size by Country
11.3.1 Middle East & Africa Imipenem API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Imipenem API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Imipenem API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Imipenem API
12.3 Imipenem API Production Process
12.4 Imipenem API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Imipenem API Typical Distributors
13.3 Imipenem API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---